# Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparing-the-efficacy-and-safety-of-galcanezumab-versus-rimegepant-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Todd J. Schwedt,Tina M. Oakes,James M. Martinez,Bert B. Vargas,Hitendra Pandey,Eric Pearlman,Diane R. Richardson,Oralee J. Varnado,Michael C. Meyer,Peter J. Goadsby |
| Citations | 44 |
| DOI | 10.1007/s40120-023-00562-w |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40120-023-00562-w.pdf |
| OpenAlex ID | https://openalex.org/W4388569081 |
| PMID | 37948006 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Oralee J. Varnado](https://scholariq.org/researchers/oralee-j-varnado/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Vestibular and auditory disorders](https://scholariq.org/topics/vestibular-and-auditory-disorders/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.